Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.
Saved in:
| Title: | Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Almeida ARM; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Neto JL; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Cachucho A; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Euzébio M; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Centro Infantil Boldrini, Campinas, SP, Brazil., Meng X; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, Paris, France., Kim R; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France, and Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212, Paris, France., Fernandes MB; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Raposo B; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Oliveira ML; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Ribeiro D; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Fragoso R; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Zenatti PP; Centro Infantil Boldrini, Campinas, SP, Brazil., Soares T; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., de Matos MR; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Corrêa JR; Centro Infantil Boldrini, Campinas, SP, Brazil., Duque M; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Roberts KG; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US., Gu Z; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US., Qu C; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US., Pereira C; Smurfit Institute of Genetics, Trinity College Dublin, University of Dublin, Dublin 2, Ireland., Pyne S; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, Scotland, UK., Pyne NJ; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, Scotland, UK., Barreto VM; DNA Breaks Laboratory, CEDOC - Chronic Diseases Research Center, NOVA Medical School - Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal., Bernard-Pierrot I; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, Paris, France., Clappier E; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France, and Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212, Paris, France., Mullighan CG; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US., Grosso AR; UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal., Yunes JA; Centro Infantil Boldrini, Campinas, SP, Brazil. andres@boldrini.org.br., Barata JT; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. joao_barata@medicina.ulisboa.pt. |
| Source: | Nature communications [Nat Commun] 2021 Dec 14; Vol. 12 (1), pp. 7268. Date of Electronic Publication: 2021 Dec 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34907175 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Almeida+ARM%22">Almeida ARM</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Neto+JL%22">Neto JL</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Cachucho+A%22">Cachucho A</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Euzébio+M%22">Euzébio M</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Centro Infantil Boldrini, Campinas, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Meng+X%22">Meng X</searchLink>; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kim+R%22">Kim R</searchLink>; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France, and Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fernandes+MB%22">Fernandes MB</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Raposo+B%22">Raposo B</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Oliveira+ML%22">Oliveira ML</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Ribeiro+D%22">Ribeiro D</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Fragoso+R%22">Fragoso R</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Zenatti+PP%22">Zenatti PP</searchLink>; Centro Infantil Boldrini, Campinas, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Soares+T%22">Soares T</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22de+Matos+MR%22">de Matos MR</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Corrêa+JR%22">Corrêa JR</searchLink>; Centro Infantil Boldrini, Campinas, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Duque+M%22">Duque M</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Roberts+KG%22">Roberts KG</searchLink>; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US.<br /><searchLink fieldCode="AU" term="%22Gu+Z%22">Gu Z</searchLink>; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US.<br /><searchLink fieldCode="AU" term="%22Qu+C%22">Qu C</searchLink>; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US.<br /><searchLink fieldCode="AU" term="%22Pereira+C%22">Pereira C</searchLink>; Smurfit Institute of Genetics, Trinity College Dublin, University of Dublin, Dublin 2, Ireland.<br /><searchLink fieldCode="AU" term="%22Pyne+S%22">Pyne S</searchLink>; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, Scotland, UK.<br /><searchLink fieldCode="AU" term="%22Pyne+NJ%22">Pyne NJ</searchLink>; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, Scotland, UK.<br /><searchLink fieldCode="AU" term="%22Barreto+VM%22">Barreto VM</searchLink>; DNA Breaks Laboratory, CEDOC - Chronic Diseases Research Center, NOVA Medical School - Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Bernard-Pierrot+I%22">Bernard-Pierrot I</searchLink>; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, Paris, France.<br /><searchLink fieldCode="AU" term="%22Clappier+E%22">Clappier E</searchLink>; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France, and Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mullighan+CG%22">Mullighan CG</searchLink>; Department of Pathology and Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, US.<br /><searchLink fieldCode="AU" term="%22Grosso+AR%22">Grosso AR</searchLink>; UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal.<br /><searchLink fieldCode="AU" term="%22Yunes+JA%22">Yunes JA</searchLink>; Centro Infantil Boldrini, Campinas, SP, Brazil. andres@boldrini.org.br.<br /><searchLink fieldCode="AU" term="%22Barata+JT%22">Barata JT</searchLink>; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. joao&#95;barata@medicina.ulisboa.pt. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Dec 14; Vol. 12 (1), pp. 7268. <i>Date of Electronic Publication: </i>2021 Dec 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34907175 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-021-27197-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 7268 Titles: – TitleFull: Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Almeida ARM – PersonEntity: Name: NameFull: Neto JL – PersonEntity: Name: NameFull: Cachucho A – PersonEntity: Name: NameFull: Euzébio M – PersonEntity: Name: NameFull: Meng X – PersonEntity: Name: NameFull: Kim R – PersonEntity: Name: NameFull: Fernandes MB – PersonEntity: Name: NameFull: Raposo B – PersonEntity: Name: NameFull: Oliveira ML – PersonEntity: Name: NameFull: Ribeiro D – PersonEntity: Name: NameFull: Fragoso R – PersonEntity: Name: NameFull: Zenatti PP – PersonEntity: Name: NameFull: Soares T – PersonEntity: Name: NameFull: de Matos MR – PersonEntity: Name: NameFull: Corrêa JR – PersonEntity: Name: NameFull: Duque M – PersonEntity: Name: NameFull: Roberts KG – PersonEntity: Name: NameFull: Gu Z – PersonEntity: Name: NameFull: Qu C – PersonEntity: Name: NameFull: Pereira C – PersonEntity: Name: NameFull: Pyne S – PersonEntity: Name: NameFull: Pyne NJ – PersonEntity: Name: NameFull: Barreto VM – PersonEntity: Name: NameFull: Bernard-Pierrot I – PersonEntity: Name: NameFull: Clappier E – PersonEntity: Name: NameFull: Mullighan CG – PersonEntity: Name: NameFull: Grosso AR – PersonEntity: Name: NameFull: Yunes JA – PersonEntity: Name: NameFull: Barata JT IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 12 Text: 2021 Dec 14 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |